Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: SERV stock price vs NEO: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at NEO's multiple
Needs NEO P/S.
Implied fair value · at SERV's multiple
Needs SERV P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: SERV FY 2025 (ended Dec 31, 2025) · NEO FY 2025 (ended Dec 31, 2025).
Trendline
Nine fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
SERVE ROBOTICS INC. · implied price per share
Bear
$0.97
Base
$1.14
Bull
$1.31
NeoGenomics, Inc. · implied price per share
Bear
-$7.04
Base
-$8.29
Bull
-$9.53
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.00x
0.64x
Net debt / EBITDA
Leverage against operating earnings
1.10x
-11.21x
Cash and equivalents
Liquid reserves on the balance sheet
$106.24M
$159.62M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
TERADYNE, INC
SERV vs TER
IROBOT CORP
SERV vs IRBT
DEXCOM INC
SERV vs DXCM
COGNEX CORP
SERV vs CGNX
ROCKWELL AUTOMATION, INC
SERV vs ROK
UiPath, Inc.
SERV vs PATH
LABCORP HOLDINGS INC.
SERV vs LH
QUEST DIAGNOSTICS INC
SERV vs DGX
OPKO HEALTH, INC.
SERV vs OPK
Guardant Health, Inc.
SERV vs GH
Natera, Inc.
SERV vs NTRA
EXACT SCIENCES CORP
SERV vs EXAS
$1.00M
$538.20M
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
Based on an earlier data snapshot. Review the filing dates below or refresh after signing in.
If you believe SERV can rapidly convert its 46.3% revenue growth into materially better margins and justify an extreme 184.2x P/S multiple, then hold or buy; otherwise, NEO-comparison data favors reducing exposure because the implied price is far below the current $6.31 quote and SERV's profitability metrics are dramatically weaker than NEO's.
SERV trades at 184.2x P/S and 144.5x EV/Revenue versus NEO at 2.7x P/S and 3.2x EV/Revenue, which implies a very large valuation premium despite much smaller scale. The provided implied price of $0.10 versus the current $6.31 suggests -98.5% downside under NEO-based P/S framework.
Supporting Metrics
